Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Prasugrel (5mg) Tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Prasuray 5 Tablet contains Prasugrel 5 mg, a thienopyridine class anti-platelet agent used to prevent platelet aggregation and reduce the risk of thrombotic events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).
Belonging to the cardiology and anti-platelet segment, Prasugrel is widely prescribed by cardiologists for secondary prevention of heart attacks and stent thrombosis. Its potent platelet inhibition ensures effective management of high-risk cardiovascular patients.
The tablet works by irreversibly inhibiting the P2Y12 receptor on platelets, reducing clot formation and improving blood flow in coronary arteries. This mechanism helps prevent recurrent cardiovascular events and supports long-term cardiac health.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Prasuray 5 Tablet offers a profitable B2B opportunity, catering to hospitals, cardiology clinics, and specialty pharmacies across India.
Common side effects may include bleeding, bruising, or mild gastrointestinal discomfort. Rare but serious side effects include severe bleeding, hemorrhagic stroke, or allergic reactions. Seek immediate medical attention if you experience unusual or prolonged bleeding, black stools, or severe dizziness.
Prasuray 5 Tablet is indicated for the prevention of thrombotic events, such as heart attack or stroke, in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). It helps reduce the risk of clot-related complications in high-risk cardiac patients.
Take Prasuray 5 Tablet exactly as prescribed and do not stop therapy without consulting your doctor. Inform your healthcare provider if you have a history of bleeding disorders, recent surgery, or are taking other blood-thinning medications. Regular monitoring may be required during treatment.
Store Prasuray 5 Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Carvedilol 3.125mg Tablet
Composition : Carvedilol CR 10mg Tablet
Composition : Carvedilol CR 20mg Tablet
Composition : Clopidogrel 150 mg Tablet
Composition : Clopidogrel 75 mg Tablet
Composition : Clopidogrel 75mg + Aspirin 150mg Tablet
Composition : Clopidogrel (75mg) + Aspirin (75mg) Tablet
Composition : Astaxanthin (16mg) + Reduced Coenzyme Q10 (200mg)
Composition : L-Methyl Folate (1mg) + Methylcobalamin (1500mcg) + Pyridoxal-5-phosphate (0.5mg) + Docosahexaenoic Acid (DHA) (200mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Prasugrel 5mg Tablet has strong demand in the cardiology, cardiovascular care, and antiplatelet therapy segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiac and chronic care portfolios.
Medical distributors and agencies can benefit from consistent demand for cardiovascular risk management and antiplatelet therapy under specialist supervision. Prasugrel 5mg is an antiplatelet medication used in cardiovascular care Commonly prescribed to help reduce the risk of blood clot formation in patients with acute coronary syndromes (ACS) and those undergoing certain cardiac procedures, as advised by healthcare professionals Helps prevent platelet aggregation, thereby supporting healthy blood flow and reducing the risk of thrombotic cardiovascular events Lower-strength formulation provides flexibility for individualized treatment plans and specific patient requirements as determined by the treating physician Oral tablet formulation offers convenient administration for long-term therapy under medical supervision Requires careful patient evaluation and monitoring due to the potential risk of bleeding complications Frequently utilized in cardiology clinics, hospitals, cardiac care centers, and specialty healthcare facilities Widely prescribed by cardiologists and cardiovascular specialists This strengthens a comprehensive cardiovascular and antiplatelet therapy portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Prasugrel 5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, long-term patient usage, repeat purchases, specialty healthcare market opportunities, reliable supply chain support, and attractive margins in the cardiovascular care segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.